CPCCOEt
CAS: 179067-99-3
Ref. 3D-EHA06799
| 5mg | Descontinuado | ||
| 10mg | Descontinuado | ||
| 25mg | Descontinuado | ||
| 50mg | Descontinuado | ||
| 100mg | Descontinuado |
Informação sobre produto
Nome:
CPCCOEt
Sinónimos:
- 7-(Hydroxyimino)Cyclopropa[B]Chromen-1A-Carboxylate Ethyl Ester
- 7-Hydroxyiminocyclopropan[B]Chromen-1A-Carboxylic Acid Ethyl Ester
- Benzo[b]cyclopropa[e]pyran-1a(1H)-carboxylic acid, 7,7a-dihydro-7-(hydroxyimino)-, ethyl ester
- Ethyl 7,7a-dihydro-7-(hydroxyimino)benzo[b]cyclopropa[e]pyran-1a(1H)-carboxylate
- ethyl (7E)-7-(hydroxyimino)-7,7a-dihydrocyclopropa[b]chromene-1a(1H)-carboxylate
Descrição:
CPCCOEt is a glutamate receptor antagonist that binds to the metabotropic glutamate receptor subtype 2 (mGluR2) and blocks its activation. CPCCOEt has been shown to inhibit the death of neurons, axonal growth, and neuronal sprouting in vitro. It also prevents the neurotoxicity induced by glutamate or NMDA in cultured cortical neurons and microdialysis probes. CPCCOEt prevents the opening of voltage-dependent calcium channels, which leads to a decrease in cytosolic Ca2+ levels. This inhibition results in an increase in neuronal survival and protection against excitotoxic injury. CPCCOEt has been shown to have a protective effect on brain damage caused by stroke or cerebral ischemia in animal models.
Aviso:
Os nossos productos estão destinados exclusivamente para uso em laboratório. Para qualquer outra aplicação, por favor entre em contacto.
Marca:
Biosynth
Armazenamento a longo prazo:
Notas:
Propriedades químicas
Peso molecular:
247.25 g/mol
Fórmula:
C13H13NO4
Pureza:
Min. 95%
MDL:
Ponto de fusão:
Ponto de ebulição:
Ponto de inflamação:
Densidade:
Concentração:
EINECS:
Merck:
Código HS:
